Viewing Study NCT01316757


Ignite Creation Date: 2025-12-24 @ 6:38 PM
Ignite Modification Date: 2026-01-03 @ 11:05 PM
Study NCT ID: NCT01316757
Status: COMPLETED
Last Update Posted: 2018-02-26
First Post: 2011-03-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer
Sponsor: Fox Chase Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma View
None Recurrent Metastatic Squamous Neck Cancer With Occult Primary View
None Recurrent Salivary Gland Cancer View
None Recurrent Squamous Cell Carcinoma of the Hypopharynx View
None Recurrent Squamous Cell Carcinoma of the Larynx View
None Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity View
None Recurrent Squamous Cell Carcinoma of the Nasopharynx View
None Recurrent Squamous Cell Carcinoma of the Oropharynx View
None Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal … View
None Recurrent Verrucous Carcinoma of the Larynx View
None Recurrent Verrucous Carcinoma of the Oral Cavity View
None Salivary Gland Squamous Cell Carcinoma View
None Stage IV Salivary Gland Cancer View
None Stage IV Squamous Cell Carcinoma of the Hypopharynx View
None Stage IV Squamous Cell Carcinoma of the Larynx View
None Stage IV Squamous Cell Carcinoma of the Lip and Oral … View
None Stage IV Squamous Cell Carcinoma of the Nasopharynx View
None Stage IV Squamous Cell Carcinoma of the Oropharynx View
None Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and … View
None Stage IV Verrucous Carcinoma of the Larynx View
None Stage IV Verrucous Carcinoma of the Oral Cavity View
None Tongue Cancer View
None Untreated Metastatic Squamous Neck Cancer With Occult Primary View
Keywords: